Diffusion Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DFFN and other ETFs, options, and stocks.

About DFFN

Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. 

CEO
Robert J. Cobuzzi
CEORobert J. Cobuzzi
Employees
16
Employees16
Headquarters
Charlottesville, Virginia
HeadquartersCharlottesville, Virginia
Founded
2001
Founded2001
Employees
16
Employees16

DFFN Key Statistics

Market cap
11.01M
Market cap11.01M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
4.55K
Average volume4.55K
High today
$5.41
High today$5.41
Low today
$5.33
Low today$5.33
Open price
$5.40
Open price$5.40
Volume
2.97K
Volume2.97K
52 Week high
$26.18
52 Week high$26.18
52 Week low
$5.10
52 Week low$5.10

DFFN Earnings

-$3.00
-$2.00
-$1.00
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, Pre-Market
ActualExpected Nov 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.